{"id":207603,"name":"ACADIA PHARMACEUTICALS, INC.","slug":"acadia-pharmaceuticals-inc","state":"CA","country":"United States of America","description":"Biopharmaceutical company.","totalSpending":1680000,"filings":22,"yearlySpending":[{"year":2020,"income":80000},{"year":2021,"income":320000},{"year":2022,"income":320000},{"year":2023,"income":320000},{"year":2024,"income":320000},{"year":2025,"income":320000}],"issues":["HCR","MMM","TAX"],"firms":["TIBER CREEK GROUP"],"lobbyists":["JONATHON JONES","JOHN GONZALEZ","ANDREW MCKECHNIE","ASHLI PALMER","BRYANT HALL","COREY MALMGREN","JOHN TWOMEY"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues affecting the pharmaceutical industry.","Issues related to the U.S. Food and Drug Administration (FDA); Issues related to drug pricing; Issues related to Medicare reform.","Issues related to the U.S. Food and Drug Administration (FDA); Issues related to drug pricing; Issues related to nursing home quality measurement.","Issues related to the U.S. Food and Drug Administration (FDA); Issues related to drug pricing; Issues related to nursing home quality measurement.","Issues related to drug pricing in H.R. 5376 - the Build Back Better Act; Issues related to nursing home quality measurement."],"years":[2020,2021,2022,2023,2024,2025]}